LFWD Lifeward Ltd. logo

LFWD Lifeward Ltd.

Healthcare
$6.98+0.00%OpenMarket Cap: $11.2M

As of 2026-05-26

Valuation

View Details

P/E (TTM)

PEG

P/B

1.81

P/S

0.51

EV/EBITDA

-0.37

DCF Value

$-215.91

FCF Yield

-139.4%

Div Yield

0.0%

Margins & Returns

Gross Margin

36.6%

Operating Margin

-120.3%

Net Margin

-123.7%

ROE

-243.1%

ROA

-77.4%

ROIC

-86.3%

Financials

View All
PeriodRevenueNet IncomeEPS
Q1 null$3.9M$-10.8M$
Q4 null$5.1M$-5.3M$
FY null$22.0M$-19.9M$
Q3 null$6.2M$-3.2M$

Analyst Ratings

View All

Consensus

Buy

Target (Consensus)

$129.00

Target (Median)

$129.00

Target Range

$102.00 - $156.00

1 Strong Buy1 Buy0 Hold0 Sell0 Strong Sell
HC Wainwright & Co.Buy
2026-03-19
HC Wainwright & Co.Buy
2025-11-18

Trading Activity

Insider Trades

View All
Rose Keith Daleofficer: Chief Medical Officer
SellWed May 20
Rose Keith Daleofficer: Chief Medical Officer
SellWed May 20
ORAMED PHARMACEUTICALS INC.10 percent owner
SellThu May 14
ORAMED PHARMACEUTICALS INC.10 percent owner
SellThu May 14
ORAMED PHARMACEUTICALS INC.10 percent owner
SellThu May 14

Company Info

Sector

Healthcare

Industry

Medical - Devices

Country

IL

Exchange

Beta

0.33

Lifeward Ltd. is a medical device company, which engages in the design, development and marketing of wearable robotic exoskeletons. The firm's exoskeletons provide hip and knee motion to enable individuals with spinal cord injury (SCI) to stand upright, walk, turn, and climb and descend stairs. Its products include ReWalk Exo-Suit and ReWalk Personal 6.0. The company was founded by Amit Goffer on June 20, 2001 and is headquartered in Marlborough, MA.

Peers